Coverage / NYSE:ELV / Trade Card

NYSE:ELV

Elevance Health Inc

BUY 2026-08-11 Data 32 days old USD 391.46 Healthcare - Medical - Healthcare PlansAWAIT ENTRY
ACTIONABLEMethodology gates passed
66

Position levels

Currenttoday
USD 391.46
Buy <=wait / entry
USD 350.00
Trim >=take some off
USD 430.00
Thesis breakA formal reduction of 2026 EPS guidance combined with a sustained deterioration ...
-

Scenario-weighted conviction

ProbabilityScoreContribution
Bull case33%100 / 10033.0
Base case51%62 / 10031.6
Bear case16%10 / 1001.6
Weighted conviction66 / 100 - BUY

Top risks

  • Raised 2026 adjusted EPS guidance to at least $27.00 in Q2 2026 results
  • Q1 and Q2 2026 operating results exceeded expectations with revenue growth from premium yields and CarelonRx
  • Analyst consensus Moderate Buy with average 12-month price target of $449.33
Read full report →

Research is for informational purposes only. Not financial advice. All analysis reflects the date of publication.